Acetyl Octapeptide-3 | CAS:NO8

We serve Acetyl Octapeptide-3 CAS:NO8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Acetyl Octapeptide-3

Chemical Name:Acetyl Octapeptide-3
CAS.NO:NA
Synonyms:Acetyl Octapeptide-3
 
Physical and Chemical Properties:
Molecular Formula C42H72N16O15S
Molecular Weight 1073.2
 
Specification:
Appearance:White powder
Assay:≥95%
Moisture:≤5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It has great water binding capacity, thus retains moisture, and makes skin smoother and soft. It has antioxidant property as well.
It saves skin from free radical damage. Similar to other peptides, it is an anti-aging and anti-wrinkle. It penetrates deep into the skin, and corrects wrinkles and fine lines.



Contact us for information like Acetyl Octapeptide-3 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Acetyl Octapeptide-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetyl Octapeptide-3 Use and application,Acetyl Octapeptide-3 technical grade,usp/ep/jp grade.


Related News: The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.Benzyl 2-Chloroethyl Ether manufacturer The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.Fmoc-Cys(Acm)-OH supplier The term active pharmaceutical ingredient may refer to an active chemical within an FDA-regulated drug, or API might mean the entire drug with its active and inactive ingredients.3-Bromo-2-fluoro-5-methylpyridine vendor Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.Cases recorded in Thailand, Taiwan, Germany, Vietnam, Japan, France and the United States involved patients who had not been to China.